DOI: https://doi.org/10.15674/0030-59872012494-98

Use of dabigatran etexilate for preventing thromboembolic complications in hip joint arthroplasty

Mykola Korzh, Volodymyr Filipenko, Frieda Leontyeva, Olexiy Tankut, Roman Malyk, Nina Yakovenko

Abstract


The article deals with results of using dabigatran etexilate mesylate, a direct inhibitor of thrombin, with a preventive purpose following primary hip joint arthroplasty. After an examination, performed on 30 patients, the efficacy of dabigatran etexilate mesylate for reducing the manifestation rate of thrombosis of veins on the lower extremities was confirmed. Besides, no significant changes in the haematological and biochemical indices of blood against a background of its use were observed.

Keywords


endoprosthesis replacement; thrombosis; prophylaxis; anticoagulants

References


Профилактика тромбоэмболических осложнений в травматологии и ортопедии: метод. рекомендации; [под ред. академика РАМН Ю. Л. Шевченко] / Р. М. Тихилов, Ю. М. Стойко, М. Н. Замятин, С. А. Божкова. — М., 2006. — 20 с.

Фурман Н. В. Значение определения уровня D-димера плазмы крови для диагностики тромбоэмболии легочной артерии / Н. В. Фурман, А. Р. Киселев, П. Я. Довгалевский // Медицина неотложных состояний. — 2008 — № 3 (16). — С. 69–91.

Закон України № 329 вiд 15.06.2007 р. [електронний ресурс] / МОЗ України. — Офіц. веб-сайт. — Режим доступу до документа: http: // www.moz.gov.ua/ua/portal/dn_20070615_329.html.

American Academy of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons clinical guideline on prevention of pulmonary embolism in patients undergoing total hip or knee arthroplasty. — 2007 May. Accessed 2008. — Oct 20.

Prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin thrombosis / C. W. Colwell, M. I. Froimson, M. A. Mont et al. // The Journal of Bone & Joint Surgery. — 2010. — Vol. 92-A. — P. 527–535.

Lieberman J. R. Prevention of venous thromboembolic disease after total hip and knee arthroplasty / J. R. Lieberman, W. K. Hsu // The Journal of Bone & Joint Surgery. — 2005. — Vol. 87-A. — P. 2097–2112.

Pharmacological basis and clinical evidence of dabigatran therapy / S. Redondo, M. P. Martínez, M. Ramajo et al. // Journal Hematology & Oncology. — 2011. — Vol. 4, № 53. — P. 2097–2112.

Meta-analyses in joint arthroplasty: a review of quantity, quality, and impact / R. Sharma, C. Vannabouathong, S. Bains et al. // The Journal of Bone & Joint Surgery. — 2011. — Vol. 93-A, № 24. — P. 2304–2309.




Copyright (c) 2014 Mykola Korzh, Volodymyr Filipenko, Frieda Leontyeva, Olexiy Tankut, Roman Malyk, Nina Yakovenko

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.